Wph.Bk
WPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare-related products and services.
Business. WPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare-related products and services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
WPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare-related products and services.
WPH.BK has a market price of 5.95 THB, with a market capitalization of 4,249,052,454.85 THB, indicating a moderate valuation. The company's price-to-earnings ratio is 12.08, and its price-to-book ratio is 2.2, suggesting that the stock is trading at a premium to its book value. The company's liquidity is rated as medium, with a current ratio of 0.97, indicating that it has nearly equal current assets to current liabilities.
In terms of profitability, WPH.BK has a return on equity of 18.25% and a return on assets of 9.82%, which are strong indicators of efficient use of equity and assets. The company's operating income of 459,498,610 THB and net income of 351,755,410 THB reflect a healthy profit margin. The gross profit of 769,593,870 THB further supports the company's strong profitability.
WPH.BK's revenue is concentrated in the healthcare sector, with no specific segment breakdown provided. The company's geographic exposure is not detailed, but its operations are primarily within the healthcare services and pharmaceuticals domain. The company's revenue of 2,329,850,480 THB is a significant figure, but the lack of segment details limits a more granular analysis.
The company's growth trajectory is not explicitly detailed, but the free cash flow of -337,334,090 THB and capital expenditure of -861,075,640 THB suggest that WPH.BK is investing heavily in its operations. The operating cash flow of 535,185,860 THB indicates that the company is generating positive cash from its operations. The debt-to-equity ratio of 0.64 suggests a moderate level of leverage.
The risk assessment for WPH.BK indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which is a key flag to monitor. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics.
Recent events and filings for WPH.BK are not detailed in the provided data. The company's financial performance and risk profile are based on the latest available financial data.
- WPH.BK has a strong return on equity of 18.25%, indicating efficient use of equity.
- The company's price-to-book ratio of 2.2 suggests it is trading at a premium to its book value.
- WPH.BK has a moderate level of leverage with a debt-to-equity ratio of 0.64.
- The company's liquidity is rated as medium, with a current ratio of 0.97.
- WPH.BK is investing heavily in its operations, as indicated by the capital expenditure of -861,075,640 THB.
- margin_outlook_rationale: The company's strong gross and operating margins suggest a positive outlook for maintaining profitability.
- rd_outlook_rationale: No specific R&D data is provided, but the company's investment in operations may include R&D activities.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- WPH.BK Market data — financials · 2026-05-30